Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.
about
Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1.Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.A nurse-led rheumatology clinic versus rheumatologist-led clinic in monitoring of patients with chronic inflammatory arthritis undergoing biological therapy: a cost comparison study in a randomised controlled trial.Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis.Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis.A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care PatientsAnalysis and Breakdown of Overall 1-Year Costs Relative to Inpatient and Outpatient Care Among Rheumatoid Arthritis Patients Treated with Biotherapies Using Health Insurance Claims Database in Alsace.Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis.Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study
P2860
Q35080243-A425534A-B664-48F7-A9C0-57BE60458EAAQ35731438-99D5449B-A782-4192-AC0D-70C8FC8453FFQ35843240-92C47D2C-746B-4E9B-81A8-0B0844E6BAD4Q36052215-03651290-3737-42FE-AEF7-0415C943E310Q36235821-2D39B3F6-557D-4EB4-8ABA-C05820EB5DAEQ36274355-A9335574-3E16-4C6D-B5CC-1E1AD0DE6CE8Q36840648-8164744B-2AE4-43FE-8498-79A2A82E0610Q36942901-3B6264BC-AF51-4A8D-A4A8-A9D739D60E8FQ37143744-FA85A7D7-5E00-45A8-B5B2-37D8784973A3Q37452967-C46F2E8E-1587-45B0-BCB8-395420386566
P2860
Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Costs of tumor necrosis factor ...... in a managed care population.
@ast
Costs of tumor necrosis factor ...... in a managed care population.
@en
type
label
Costs of tumor necrosis factor ...... in a managed care population.
@ast
Costs of tumor necrosis factor ...... in a managed care population.
@en
prefLabel
Costs of tumor necrosis factor ...... in a managed care population.
@ast
Costs of tumor necrosis factor ...... in a managed care population.
@en
P2093
P1476
Costs of tumor necrosis factor ...... in a managed care population.
@en
P2093
Chakkarin Burudpakdee
David J Harrison
George J Joseph
Paige Iversen
Vernon F Schabert
P304
P356
10.18553/JMCP.2013.19.8.621
P577
2013-10-01T00:00:00Z